Celgene Corporation (CELG)
Add to Watchlists Create an AlertCelgene Corporation Enterprise Value:
50.74B for May 24, 2013Celgene Corporation Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 24, 2013 | 50.74B |
| May 23, 2013 | 51.18B |
| May 22, 2013 | 51.10B |
| May 21, 2013 | 51.12B |
| May 20, 2013 | 50.96B |
| May 17, 2013 | 51.71B |
| May 16, 2013 | 51.11B |
| May 15, 2013 | 53.68B |
| May 14, 2013 | 53.90B |
| May 13, 2013 | 53.69B |
| May 10, 2013 | 52.77B |
| May 9, 2013 | 50.79B |
| May 8, 2013 | 50.80B |
| May 7, 2013 | 50.35B |
| May 6, 2013 | 50.17B |
| May 3, 2013 | 50.34B |
| May 2, 2013 | 49.35B |
| May 1, 2013 | 48.27B |
| April 30, 2013 | 48.86B |
| April 29, 2013 | 49.02B |
| April 26, 2013 | 49.80B |
| April 25, 2013 | 48.81B |
| April 24, 2013 | 48.94B |
| April 23, 2013 | 52.16B |
| April 22, 2013 | 52.64B |
| April 19, 2013 | 50.76B |
| April 18, 2013 | 49.39B |
| April 17, 2013 | 50.34B |
| April 16, 2013 | 50.82B |
| April 15, 2013 | 49.93B |
| April 12, 2013 | 51.03B |
| April 11, 2013 | 51.03B |
| April 10, 2013 | 50.12B |
| April 9, 2013 | 48.36B |
| April 8, 2013 | 48.41B |
| April 5, 2013 | 48.28B |
| April 4, 2013 | 48.08B |
| April 3, 2013 | 47.92B |
| April 2, 2013 | 48.85B |
| April 1, 2013 | 48.54B |
| March 28, 2013 | 47.72B |
| March 27, 2013 | 46.60B |
| March 26, 2013 | 46.28B |
| March 25, 2013 | 45.99B |
| March 22, 2013 | 46.55B |
| March 21, 2013 | 46.09B |
| March 20, 2013 | 46.21B |
| March 19, 2013 | 45.68B |
| March 18, 2013 | 46.04B |
| March 15, 2013 | 46.25B |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
CELG Enterprise Value Benchmarks
| Companies | |
|---|---|
| Amgen | 82.05B |
| Athersys | 69.26M |
| Gilead Sciences | 90.48B |
CELG Enterprise Value Rankings
| Overall |
97th percentile 154 of 7600 |
| Sector |
97th percentile 19 of 653 in Healthcare |
| Industry |
97th percentile 5 of 238 in Biotechnology |
CELG Enterprise Value Range, Past 5 Years
| Minimum | 15.07B | Apr 20 2009 |
| Maximum | 53.90B | May 14 2013 |
| Average | 26.79B |
